Stevenage, England, United Kingdom
I am a self motivated, highly organised and enthusiastic team player with excellent networking and communication skills. With 24 years experience in the pharmaceutical industry I have gained experience of a diverse range of drug discovery and development activities which I am able to use in my role as an Operations Director (7 years experience in Operations) supporting a team of ~100 scientists. Principal activities include: - Drafting and negotiating contracts to facilitate collaborations with external companies and academic groups - Management and forecasting of an annual budget of ~£38M - Ensuring full compliance with legal requirements and internal policy commitments; - Management of 15 chemistry FTEs at a CRO in asia, including scientific direction and guidance I have a demonstrated track record of multi-tasking, prioritisation, cross-matrix working and flexibility combined with excellent time management skills which has ensured a highly productive track record both individually and as part of (or leading) a team. Successful implementation of innovative solutions to identified problems has delivered cost or efficiency savings >£0.5M p.a.
Operations Manager supporting a dept of ~55 scientists in the Epigenetic and Immuno-Inflammation therapy areas with responsibilities including Budget management (£6M p.a.), Academic collaboration contract negotiations (~50 per year), Safety, Risk management & Compliance, External CRO Outsourcing & Management (15 FTEs).
12 years experience in medicinal chemistry with leadership and management experience and a record of delivery of probe and candidate molecules, particularly in Epigenetics and Immuno-Inflammation. Extensive synthetic chemistry experience. Delivery of scientific presentations at international conferences to an audience of 500 peers. Previous member of the Scientific Advisory Board for a key instrumentation supplier and recognised as a Key Opinion Leader in flash purification 2002-2008.
Synthetic chemist working in anti-inflammatory, infective and cardiovascular therapies.